Curcumin's Role in Treating Acute Myeloid Leukemia
Author Information
Author(s): Rao Jia, Xu Duo-Rong, Zheng Fei-Meng, Long Zi-Jie, Huang Sheng-Shan, Wu Xing, Zhou Wei-Hua, Huang Ren-Wei, Liu Quentin
Primary Institution: Sun Yat-sen University
Hypothesis
Curcumin can induce apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cells.
Conclusion
Curcumin down-regulates Bcl-2 and induces apoptosis in daunorubicin-insensitive CD34+ AML cell lines and primary CD34+ AML cells.
Supporting Evidence
- Curcumin significantly inhibited proliferation in both DNR-insensitive and DNR-sensitive AML cell lines.
- Curcumin induced apoptosis through activation of caspase-3 and down-regulation of Bcl-2.
- Co-treatment with curcumin and DNR showed synergistic effects in inhibiting cell growth.
- Primary CD34+ AML cells were also sensitive to curcumin treatment.
Takeaway
Curcumin, a compound in turmeric, helps kill certain leukemia cells that are usually resistant to treatment by lowering a protein called Bcl-2.
Methodology
The study involved isolating CD34+ cells and treating them with curcumin, followed by various assays to assess cell viability and apoptosis.
Potential Biases
Potential bias in patient selection and treatment response assessment.
Limitations
The study primarily focused on specific cell lines and may not fully represent all AML cases.
Participant Demographics
Included 9 newly diagnosed AML patients and 8 healthy donors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website